Mangalore Chemicals & Fertilizers Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: June 24, 2025, 9:32 pm

Competitors of Mangalore Chemicals & Fertilizers Ltd

All Competitor Stocks of Mangalore Chemicals & Fertilizers Ltd

Quarterly Result

Last Updated: May 31, 2025, 8:28 am

Below is a detailed analysis of the quarterly data for Mangalore Chemicals & Fertilizers Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 774.00 Cr.. The value appears to be declining and may need further review. It has decreased from 968.00 Cr. (Dec 2024) to 774.00 Cr., marking a decrease of 194.00 Cr..
• For Expenses, as of Mar 2025, the value is 736.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 865.00 Cr. (Dec 2024) to 736.00 Cr., marking a decrease of 129.00 Cr..
• For Operating Profit, as of Mar 2025, the value is 38.00 Cr.. The value appears to be declining and may need further review. It has decreased from 103.00 Cr. (Dec 2024) to 38.00 Cr., marking a decrease of 65.00 Cr..
• For OPM %, as of Mar 2025, the value is 5.00%. The value appears to be declining and may need further review. It has decreased from 11.00% (Dec 2024) to 5.00%, marking a decrease of 6.00%.
• For Other Income, as of Mar 2025, the value is 18.00 Cr.. The value appears strong and on an upward trend. It has increased from 7.00 Cr. (Dec 2024) to 18.00 Cr., marking an increase of 11.00 Cr..
• For Interest, as of Mar 2025, the value is 15.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 16.00 Cr. (Dec 2024) to 15.00 Cr., marking a decrease of 1.00 Cr..
• For Depreciation, as of Mar 2025, the value is 19.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 19.00 Cr..
• For Profit before tax, as of Mar 2025, the value is 22.00 Cr.. The value appears to be declining and may need further review. It has decreased from 75.00 Cr. (Dec 2024) to 22.00 Cr., marking a decrease of 53.00 Cr..
• For Tax %, as of Mar 2025, the value is 26.00%. The value appears to be increasing, which may not be favorable. It has increased from 23.00% (Dec 2024) to 26.00%, marking an increase of 3.00%.
• For Net Profit, as of Mar 2025, the value is 16.00 Cr.. The value appears to be declining and may need further review. It has decreased from 57.00 Cr. (Dec 2024) to 16.00 Cr., marking a decrease of 41.00 Cr..
• For EPS in Rs, as of Mar 2025, the value is 1.35. The value appears to be declining and may need further review. It has decreased from 4.84 (Dec 2024) to 1.35, marking a decrease of 3.49.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: May 15, 2025, 5:57 am

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: June 16, 2025, 11:44 am

Below is a detailed analysis of the balance sheet data for Mangalore Chemicals & Fertilizers Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 119.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 119.00 Cr..
• For Reserves, as of Mar 2025, the value is 946.00 Cr.. The value appears strong and on an upward trend. It has increased from 821.00 Cr. (Mar 2024) to 946.00 Cr., marking an increase of 125.00 Cr..
• For Borrowings, as of Mar 2025, the value is 741.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 1,039.00 Cr. (Mar 2024) to 741.00 Cr., marking a decrease of 298.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 527.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 452.00 Cr. (Mar 2024) to 527.00 Cr., marking an increase of 75.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 2,333.00 Cr.. The value appears to be improving (decreasing). It has decreased from 2,430.00 Cr. (Mar 2024) to 2,333.00 Cr., marking a decrease of 97.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 1,021.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,082.00 Cr. (Mar 2024) to 1,021.00 Cr., marking a decrease of 61.00 Cr..
• For CWIP, as of Mar 2025, the value is 31.00 Cr.. The value appears strong and on an upward trend. It has increased from 11.00 Cr. (Mar 2024) to 31.00 Cr., marking an increase of 20.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Assets, as of Mar 2025, the value is 1,280.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,337.00 Cr. (Mar 2024) to 1,280.00 Cr., marking a decrease of 57.00 Cr..
• For Total Assets, as of Mar 2025, the value is 2,333.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,430.00 Cr. (Mar 2024) to 2,333.00 Cr., marking a decrease of 97.00 Cr..

Notably, the Reserves (946.00 Cr.) exceed the Borrowings (741.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Key Financial Ratios

After reviewing the key financial ratios for Mangalore Chemicals & Fertilizers Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 12.13. This value is within the healthy range. It has decreased from 13.06 (Mar 24) to 12.13, marking a decrease of 0.93.
• For Diluted EPS (Rs.), as of Mar 25, the value is 12.13. This value is within the healthy range. It has decreased from 13.06 (Mar 24) to 12.13, marking a decrease of 0.93.
• For Cash EPS (Rs.), as of Mar 25, the value is 18.54. This value is within the healthy range. It has decreased from 19.10 (Mar 24) to 18.54, marking a decrease of 0.56.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 89.81. It has increased from 79.27 (Mar 24) to 89.81, marking an increase of 10.54.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 89.81. It has increased from 79.27 (Mar 24) to 89.81, marking an increase of 10.54.
• For Dividend / Share (Rs.), as of Mar 25, the value is 1.50. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.50.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 281.06. It has decreased from 320.16 (Mar 24) to 281.06, marking a decrease of 39.10.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 30.25. This value is within the healthy range. It has decreased from 35.19 (Mar 24) to 30.25, marking a decrease of 4.94.
• For PBIT / Share (Rs.), as of Mar 25, the value is 23.82. This value is within the healthy range. It has decreased from 29.15 (Mar 24) to 23.82, marking a decrease of 5.33.
• For PBT / Share (Rs.), as of Mar 25, the value is 17.38. This value is within the healthy range. It has decreased from 20.30 (Mar 24) to 17.38, marking a decrease of 2.92.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 12.12. This value is within the healthy range. It has decreased from 13.06 (Mar 24) to 12.12, marking a decrease of 0.94.
• For PBDIT Margin (%), as of Mar 25, the value is 10.76. This value is within the healthy range. It has decreased from 10.99 (Mar 24) to 10.76, marking a decrease of 0.23.
• For PBIT Margin (%), as of Mar 25, the value is 8.47. This value is below the healthy minimum of 10. It has decreased from 9.10 (Mar 24) to 8.47, marking a decrease of 0.63.
• For PBT Margin (%), as of Mar 25, the value is 6.18. This value is below the healthy minimum of 10. It has decreased from 6.34 (Mar 24) to 6.18, marking a decrease of 0.16.
• For Net Profit Margin (%), as of Mar 25, the value is 4.31. This value is below the healthy minimum of 5. It has increased from 4.07 (Mar 24) to 4.31, marking an increase of 0.24.
• For Return on Networth / Equity (%), as of Mar 25, the value is 13.49. This value is below the healthy minimum of 15. It has decreased from 16.47 (Mar 24) to 13.49, marking a decrease of 2.98.
• For Return on Capital Employeed (%), as of Mar 25, the value is 19.66. This value is within the healthy range. It has decreased from 25.15 (Mar 24) to 19.66, marking a decrease of 5.49.
• For Return On Assets (%), as of Mar 25, the value is 6.16. This value is within the healthy range. It has decreased from 6.36 (Mar 24) to 6.16, marking a decrease of 0.20.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.21. This value is within the healthy range. It has decreased from 0.31 (Mar 24) to 0.21, marking a decrease of 0.10.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.67. This value is within the healthy range. It has decreased from 1.08 (Mar 24) to 0.67, marking a decrease of 0.41.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.40. It has decreased from 1.49 (Mar 24) to 1.40, marking a decrease of 0.09.
• For Current Ratio (X), as of Mar 25, the value is 1.34. This value is below the healthy minimum of 1.5. It has increased from 1.23 (Mar 24) to 1.34, marking an increase of 0.11.
• For Quick Ratio (X), as of Mar 25, the value is 1.04. This value is within the healthy range. It has decreased from 1.08 (Mar 24) to 1.04, marking a decrease of 0.04.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 8.42. This value exceeds the healthy maximum of 8. It has decreased from 9.05 (Mar 24) to 8.42, marking a decrease of 0.63.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 11.48 (Mar 24) to 0.00, marking a decrease of 11.48.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 7.85 (Mar 24) to 0.00, marking a decrease of 7.85.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 88.52 (Mar 24) to 0.00, marking a decrease of 88.52.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 92.15 (Mar 24) to 0.00, marking a decrease of 92.15.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 4.69. This value is within the healthy range. It has increased from 3.98 (Mar 24) to 4.69, marking an increase of 0.71.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.88. This value is below the healthy minimum of 3. It has increased from 2.48 (Mar 24) to 2.88, marking an increase of 0.40.
• For Enterprise Value (Cr.), as of Mar 25, the value is 2,436.57. It has increased from 1,893.83 (Mar 24) to 2,436.57, marking an increase of 542.74.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.73. This value is below the healthy minimum of 1. It has increased from 0.49 (Mar 24) to 0.73, marking an increase of 0.24.
• For EV / EBITDA (X), as of Mar 25, the value is 6.80. This value is within the healthy range. It has increased from 4.54 (Mar 24) to 6.80, marking an increase of 2.26.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.55. This value is below the healthy minimum of 1. It has increased from 0.31 (Mar 24) to 0.55, marking an increase of 0.24.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 88.51 (Mar 24) to 0.00, marking a decrease of 88.51.
• For Price / BV (X), as of Mar 25, the value is 1.73. This value is within the healthy range. It has increased from 1.28 (Mar 24) to 1.73, marking an increase of 0.45.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.55. This value is below the healthy minimum of 1. It has increased from 0.31 (Mar 24) to 0.55, marking an increase of 0.24.
• For EarningsYield, as of Mar 25, the value is 0.07. This value is below the healthy minimum of 5. It has decreased from 0.12 (Mar 24) to 0.07, marking a decrease of 0.05.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness